Pluri Inc (PLUR) Options

July Company Presentation:

https://pluri-biotech.com/wp-content/uploads/2024/07/Pluri-PPT-investor_Q2_July_2024-final.pdf

https://pluri-biotech.com/releases/pluri-announces-e1-million-proof-of-concept-agreement-to-enhance-global-sustainable-vegetable-supply/

Pluri Announces €1 Million Proof of Concept Agreement to Enhance Global Sustainable Vegetable Supply

https://www.streetinsider.com/Globe+Newswire/Pluri+Announces+%E2%82%AC1+Million+Proof+of+Concept+Agreement+to+Enhance+Global+Sustainable+Vegetable+Supply/23438713.html

PLUR under $10

"Don’t write off cultivated meat just yet, says Ever After Foods: ‘We’re not offering incremental improvements but something truly disruptive."

https://agfundernews.com/dont-write-off-cultivated-meat-just-yet-says-ever-after-foods-were-not-offering-incremental-improvements-but-something-truly-disruptive

WOW !!!

https://agfundernews.com/dont-write-off-cultivated-meat-just-yet-says-ever-after-foods-were-not-offering-incremental-improvements-but-something-truly-disruptive

Dr. Michal Sheleg on a Novel Immunotherapy Platform for Solid Tumor Treatment

https://docwirenews.com/post/dr-michal-sheleg-on-a-novel-immunotherapy-platform-for-solid-tumor-treatment

New Immune Cell Patent !!!

IMO...PLURI BIOTECH WILL DOMINATE THE GLOBAL IMMUNE CELL EXPANSION MARKET !!!

Expanded To Many Types Of Immune Cells !!

Immune cells are one of Jurkat, T2 cells, K562 cells, Raji, U973, THP-1, HL-60, Peripheral Blood Mononuclear Cells (PBMC), polymorphonuclear cells (PMN), conventional and unconventional T cells, B cells, B cell Hybridomas, CAR-B, NKT cells, CAR-NKT, gamma-delta T (gdT), CAR-gdT, NK cells, CAR-NK, and combinations thereof. Said conventional or unconventional T-Cell immune cells are unmodified or modified T cells consisting of the group: CAR-T, CAR-MAIT, modified T cell receptor (TCR)-T, modified TCR-MAIT, TILs (Tumor Infiltrating Lymphocytes), and combinations thereof.

The method according to claim 18, further comprising a step of genetically modifying said population of immune cells inside said 3D bioreactor by adding to said fluid media one or more gene modifying agents capable of genetically modifying said population of immune cells suspended in said fluid media spiked into said fluid media.

https://patentscope.wipo.int/search/en/detail.jsf?docId=US431346161&_cid=P12-LXQ3ZQ-63878-1

Pluri: Biotech Play With Several Opportunities Across Different Sectors

https://seekingalpha.com/article/4699864-pluri-several-opportunities-across-different-sectors

Excellent !!!

https://www.greenqueen.com.hk/ever-after-foods-pluri-tnuva-cultivated-meat-costs-scalability/

After Doing More Research On Buhler AG, They Are Probably Not Making Ever After' Foods Bioreactors.

After Doing More Research On Buhler AG, They Are Probably Not Making Ever After' Foods Bioreactors.

Ever After Foods Sold Shares To: (CSFC Investments), Which Is Cargill Financial Service Corporation, As Well As To: Interfonda, A Part Of Buhler AG, The Company That Will Be Building Ever After Foods Bioreactors. Very Exciting News !!!

SHARE PURCHASE AGREEMENT

This Share Purchase Agreement (this “Agreement”) is entered into on June 12, 2024, by and among (i) Ever After Foods Ltd., a company incorporated in Israel, Reg. No. 516502556 with a registered address at M.T.M – Scientific Industries Centre, building 5, Haifa 3508409, Israel (formerly known as Plurinuva Ltd. - the “Company”), (ii) CFSC Investments, Inc., a Delaware corporation, with a principal mailing address at 15407 McGinty Road West, Wayzata, Minnesota 55391, United States (“CFSC”), (iii) Interfonda AG, a company incorporated in Switzerland, Reg. No. CHE-102.588.792 with a registered address at c/o [**], Gupfenstrasse 5, 9240 Uzwil, Switzerland (“Interfonda”), (iv) Tnuva Food-Tech Incubator (2019), Limited Partnership, Reg. No. 540287620 with a registered address at 21 Yagia Kapayim Street, Kiryat Arie, POB 300, Petah Tikva 4910201, Israel (“Tnuva”), (v) Pluri Biotech Ltd., a company incorporated in Israel, Reg. No. 513371666 with a registered address at M.T.M – Scientific Industries Centre, building 5, Haifa 3508409, Israel (“Pluri”, and together with CFSC, Interfonda, and Tnuva, the “Lead Investors”), and (vi) the other person(s) and/or entity(ies) listed in Exhibit A attached hereto, as may be updated from time to time (each of CFSC, Tnuva, Pluri, Interfonda, and such other person or entity, an “Investor”, and, severally and not jointly, the “Investors”) on the other side.

https://www.sec.gov/ix?doc=/Archives/edgar/data/1158780/000121390024053515/ea0207508-8k_pluri.htm

Pluri Subsidiary Ever After Foods Secured $10 Million Strategic Investment to Solve Cultivated Food Scalability Challenges

https://pluri-biotech.com/releases/pluri-subsidiary-ever-after-foods-secured-10-million-strategic-investment-to-solve-cultivated-food-scalability-challenges/

Pluri Subsidiary Ever After Foods Secured $10 Million Strategic Investment to Solve Cultivated Food Scalability Challenges

https://pluri-biotech.com/releases/pluri-subsidiary-ever-after-foods-secured-10-million-strategic-investment-to-solve-cultivated-food-scalability-challenges/

Go Ever After Foods !!!

https://www.thefencepost.com/news/up-to-500m-earmarked-by-dod-for-cell-cultured-meat-research-and-development/

Pluri bags $1.4m to advance nuclear radiation therapy.

https://www.bioprocessintl.com/therapeutic-class/pluri-bags-1-4m-to-advance-nuclear-radiation-therapy

Pluri Biotech Press Release:

https://pluri-biotech.com/releases/u-s-national-institutes-of-health-exercises-option-to-fund-1-4-million-2nd-year-budget-for-pluris-plx-r18-acute-radiation-syndrome-contract/

A CBO of a company that’s been trying to find a business for the last 25 years with ZERO success. Priceless. Right up there with their marketing department with nothing to market.

Whatever happened to Zzatty boy. I really miss his WE GOT ZZIENTISTS. Can’t get out of bed anymore I guess since he’s pretty much lost everything after suffering 2 reverse splits. But I’m sure he still loves management. Especially Kaki.

Pluri's MAIT Cell Program

3D Cell-Expansion Technology Revolutionizing Industries: Interview with Lior Raviv, Chief Technology Officer at Pluri

https://techbullion.com/3d-cell-expansion-technology-revolutionizing-industries-interview-with-lior-raviv-chief-technology-officer-at-pluri/

Keep The Comedy Coming Midas!!! Glad To See You Are Still Able To Crawl Out From Under Your Rock Once In A While !!!

Item 3.01 Notice of Delisting or Failure to Satisfy a Continug le Ruor Standard; Transfer of Listing.ed Listin

On May 28, 2024, Pluri Inc., or Pluri or the Company, received a deficiency letter, or the Nasdaq Letter, from the Listing Qualifications Department of The Nasdaq Stock Market LLC, or Nasdaq, notifying the Company that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires the Company to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing on The Nasdaq Capital Market, or the Stockholders’ Equity Requirement, nor is it in compliance with either of the alternative listing standards, market value of listed securities of at least $35 million or net income of $500,000 from continuing operations in the most recently completed fiscal year, or in two of the three most recently completed fiscal years.

Pursuant to the Nasdaq Letter, the Company has 45 calendar days from the date of the Nasdaq Letter to submit a plan to regain compliance and the Company intends to submit such a plan during this period. If it accepts the plan, Nasdaq can grant an extension of up to 180 calendar days from the date of the Nasdaq Letter to evidence compliance. In the event the plan is not accepted by Nasdaq, or in the event the plan is accepted and the 180-day extension period granted but the Company fails to regain compliance within such plan period, the Company would have the right to a hearing before an independent panel. The hearing request would stay any suspension or delisting action pending the conclusion of the hearing process and the expiration of any additional extension period granted by the panel following the hearing.

The Company intends to take all reasonable measures available to regain compliance under the Nasdaq Listing Rules and remain listed on Nasdaq. However, there can be no assurance that Nasdaq will grant the Company’s request for an extension or that the Company will ultimately regain compliance with all applicable requirements for continued listing.

Neither the Nasdaq Letter nor the Company’s noncompliance have an immediate effect on the listing or trading of the Company’s common shares, which will continue to trade on The Nasdaq Capital Market under the symbol “PLUR”.
-------------------------------------------------------------------------------------------------------
Seems that a r/s was not sufficient

Pluri Biotech In California Next Week !!!

https://convention.bio.org/

The only product this company has ever produced in 10 years is potential. Amazing how you can make money from nothing.

Always a ton of pootential with the clown crew. Would have tripled their revenue by just selling their clown noses.

Huge Market Potential !!!

https://www.proteinproductiontechnology.com/post/pluri-and-wilk-collaborate-to-develop-human-breast-milk-derived-food-production-on-a-commercial-scale

All the fluff in the world is doing jack squat for this pig. They’re getting desperate and you’ll see a raise very soon I’m sure. Like clockwork.

All the fluff in the world is doing jack squat for this pig. They’re getting desperate and you’ll see a raise very soon I’m sure. Like clockwork.

Cmon the whole world is going to feed their babies manufactured milk. They won’t try a piece of meat but they’re gonna slap that bottle of grown milk into their kids chops. Once approval happens in 2058, it’ll be smooth sailing for Kaki and his clown crew.

You're wasting your time with these scam "updates". This well dried up for the clowns a long time ago.
Only newbie suckers who don't read message boards are available to be fleeced.

WOW !!! Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale

https://pluri-biotech.com/releases/novel-medical-food-solution-for-the-elderly-pluri-wilk-collaborate-to-develop-human-breast-milk-derived-food-production-on-a-commercial-scale/

Wow....This Is A Game-Changer !!!

https://pluri-biotech.com/mait-pluri-health/

Yes they’re in the discovery phase of their solid tumor investigations. Woohoo!!! Didn’t they mention this a decade ago? Only ten short years to get to the discover phase of this earth shattering news they announced. In a mere 2 centuries, they should have completed their phase 1, them pivot back to ARS or preeclampsia.

What’s even more impressive is how Kaki is using the exact same verbiage the og clown Zami used for 15 years. A few it’s and ands changed around, but pretty much identical speeches. Hey when you got a good legal scam going, why change a thing.

WOW !!!

Well how many times have we seen this. Any day we should get a raise at a 10 to 20% discount. It’s imminent imo

All aboard the Titanic!!
What a joke of a stock. Moves up 10% on 12,000 shares traded.
Gimme a break. Wake me when we get back to a dollar.

Pluri CDMO: Chief Commercial Officer Andy Lewin Interview

https://www.phacilitate.com/learning-from-experience-navigating-cell-gene-therapy-development-challenges-with-productive-cdmo-partnerships/

All Aboard !!!

https://kenes-exhibitions.com/biomed/?gad_source=1&gclid=Cj0KCQjwhtWvBhD9ARIsAOP0Gohffys13bxoPAqgDNYKFt4scQqwrv2c1YT4zfGxHSRe8M_euOMMy9YaAinLEALw_wcB

Pluri Biotech May Investor Presentation Is Out !!!

https://pluri-biotech.com/presentation/

And in 10 years they should have their phase 1 results. Good thing companies like Merck below, are just starting phase 3 trials on solid tumors. Pluristem with all their ex Elbit Vision System employees should be able to leapfrog Merck’s trials in a couple decades.

https://www.merck.com/news/merck-announces-phase-3-trial-initiations-for-four-investigational-candidates-from-its-promising-hematology-and-oncology-pipeline/

Or all these other trials going on. But ya Pluristem and Kaki the accountant clown got this.

https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-023-01723-z

Incredible, Pluri Has Developed A Fully Allogeneic CD8 Positive T-Cell That Is A Off-The-Shelf Solid Tumor Treatment And Grown On An Industrial Scale !!!

ONLY ONE IN THE WORLD FOLKS-Pay Attention To What's Coming !!!

MAIT cells are a type of T cell, which is responsible for attacking harmful pathogens in the body like cancer cells. MAIT cells, however, are not well understood compared to other immune cells. Aug 17, 2023

They peddled this years ago. They’re just rehashing headlines to dupe a new slew of investors to keep the paycheques coming for the 150 plus employees who have billed investors out of soon to be half a billion dollars with zero to show for it over 20 years and Zzatty boys going to have a freak out over this run on sentence while screaming we got Zzientists after going through his second rs making the tens of thousands of shares he bought over $20 that are now at a price of $160 after the last rs. Hey didn’t he call ME an idiot many times? LMAO x200k

Those original 200k shares he bragged about went down to 20k shares after the first 1 for 10. Now after the last 1 for 8 its down to 2500 shares. Oh the humanity. Not to worry though. To imagine going from 200,000 shares to 2500 shares must have been devastating. But he still loves this management team no doubt. And don’t forget, he’s seen splits before that have worked out.

Can only laugh at this point. But I’m sure he’s going to have a massive Chubb after learning about a new scientific board. Kinda reminds me of the preeclampsia board they put together for their pre clinical studies that went nowhere like everything else they’ve touched.

And you’ll be happy to know I’ve come up with Pluristem’s new motto.

Pluristem…The Perpetual Startup.

WOW !!! WOW !!! WOW !!! WOW !!! WOW !!!

https://pluri-biotech.com/releases/unleashing-the-power-of-mait-cells-pluri-launches-novel-immunotherapy-platform-for-solid-tumor-cancer-treatment/

PLURI BIOTECH SHAREHOLDER MEETING IS JUNE 25TH !!!

https://www.sec.gov/Archives/edgar/data/1158780/000121390024038145/ea0204843-def14a_pluri.htm

PLUR under $10

Correction: The TASE Is Closed Sunday & Monday

Listen To What Yaky Says At The 3 Minute and 15 Second Point !!!

WOW !!! Ever After Foods Is Going BIG TIME !!!